2022 Q1 Form 10-K Financial Statement

#000155837022005383 Filed on April 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $125.6M $509.4M $117.2M
YoY Change 7.14% 29.87% 72.35%
Cost Of Revenue $103.3M $409.6M $95.20M
YoY Change 8.55% 24.08% 51.83%
Gross Profit $22.23M $99.73M $22.10M
YoY Change 0.59% 60.68% 325.0%
Gross Profit Margin 17.7% 19.58% 18.86%
Selling, General & Admin $15.51M $47.32M $10.20M
YoY Change 52.04% 21.21% -17.74%
% of Gross Profit 69.76% 47.45% 46.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $997.0K $3.367M $1.100M
YoY Change -9.36% -9.37% 0.0%
% of Gross Profit 4.48% 3.38% 4.98%
Operating Expenses $15.51M $47.32M $10.20M
YoY Change 52.04% 21.21% -17.74%
Operating Profit $6.723M $44.51M $11.90M
YoY Change -43.5% 93.3% -265.28%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $983.0K $2.552M $100.0K
YoY Change 883.0% 37.28% -83.33%
Pretax Income -$195.0K $47.06M $12.00M
YoY Change -101.63% 89.12% -229.03%
Income Tax $128.0K $11.36M $2.500M
% Of Pretax Income 24.13% 20.83%
Net Earnings $2.215M $38.24M $9.600M
YoY Change -76.93% 60.35% -233.33%
Net Earnings / Revenue 1.76% 7.51% 8.19%
Basic Earnings Per Share $2.43
Diluted Earnings Per Share $141.0K $2.40 $603.8K
COMMON SHARES
Basic Shares Outstanding 15.72M
Diluted Shares Outstanding 15.91M

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $440.5M $440.5M $456.7M
YoY Change -3.55% -3.55% 39.28%
Cash & Equivalents $350.5M $350.5M $366.7M
Short-Term Investments $90.03M $90.03M $90.10M
Other Short-Term Assets $34.90M $34.90M $34.15M
YoY Change 2.22% 2.36% 46.41%
Inventory
Prepaid Expenses $2.954M
Receivables $26.98M $31.88M $28.71M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $507.3M $507.3M $546.2M
YoY Change -7.13% -7.12% 29.51%
LONG-TERM ASSETS
Property, Plant & Equipment $10.46M $14.49M $20.36M
YoY Change -48.63% -39.88% -9.66%
Goodwill $28.03M $27.94M
YoY Change 0.32% 0.0%
Intangibles $3.322M $4.097M
YoY Change -18.92% -18.08%
Long-Term Investments $200.0K
YoY Change
Other Assets $457.0K $457.0K $200.0K
YoY Change 128.5% 128.5% -97.59%
Total Long-Term Assets $46.30M $46.30M $56.41M
YoY Change -17.92% -17.91% -14.25%
TOTAL ASSETS
Total Short-Term Assets $507.3M $507.3M $546.2M
Total Long-Term Assets $46.30M $46.30M $56.41M
Total Assets $553.6M $553.6M $602.6M
YoY Change -8.14% -8.13% 23.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.82M $41.82M $53.30M
YoY Change -21.53% -21.53% 50.37%
Accrued Expenses $53.32M $53.32M $50.75M
YoY Change 5.05% 4.95% 41.34%
Deferred Revenue $127.9M $172.0M
YoY Change -25.66% 136.7%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $223.0M $223.0M $276.1M
YoY Change -19.22% -19.22% 91.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.963M $4.963M $4.135M
YoY Change 20.02% 21.05% 67.0%
Total Long-Term Liabilities $4.963M $4.963M $4.135M
YoY Change 20.02% 21.05% 67.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $223.0M $223.0M $276.1M
Total Long-Term Liabilities $4.963M $4.963M $4.135M
Total Liabilities $228.0M $227.2M $280.2M
YoY Change -18.64% -19.44% 91.26%
SHAREHOLDERS EQUITY
Retained Earnings $188.7M $166.1M
YoY Change 13.59% -12.25%
Common Stock $160.6M $155.7M
YoY Change 3.14% 3.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.41M $33.00K
YoY Change 61733.33%
Treasury Stock Shares $531.0K $3.233K
Shareholders Equity $326.4M $326.4M $320.7M
YoY Change
Total Liabilities & Shareholders Equity $553.6M $553.6M $602.6M
YoY Change -8.14% -8.13% 23.61%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income $2.215M $38.24M $9.600M
YoY Change -76.93% 60.35% -233.33%
Depreciation, Depletion And Amortization $997.0K $3.367M $1.100M
YoY Change -9.36% -9.37% 0.0%
Cash From Operating Activities -$13.28M $28.42M $32.10M
YoY Change -141.38% -83.86% -14.85%
INVESTING ACTIVITIES
Capital Expenditures -$299.0K $1.422M -$300.0K
YoY Change -0.33% -16.21% -62.5%
Acquisitions
YoY Change
Other Investing Activities -$1.531M -$5.616M $0.00
YoY Change -108.02% -100.0%
Cash From Investing Activities -$1.830M -$7.038M -$300.0K
YoY Change 510.0% -110.51% -99.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.37M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.17M -34.61M -19.20M
YoY Change 25.9% -23.78% 392.31%
NET CHANGE
Cash From Operating Activities -13.28M 28.42M 32.10M
Cash From Investing Activities -1.830M -7.038M -300.0K
Cash From Financing Activities -24.17M -34.61M -19.20M
Net Change In Cash -39.29M -16.20M 12.60M
YoY Change -411.8% -108.13% -114.82%
FREE CASH FLOW
Cash From Operating Activities -$13.28M $28.42M $32.10M
Capital Expenditures -$299.0K $1.422M -$300.0K
Free Cash Flow -$12.98M $26.99M $32.40M
YoY Change -140.08% -84.51% -15.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000100591
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
ARGAN INC
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-01-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-31756
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1947195
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
One Church Street, Suite 201
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2022 dei City Area Code
CityAreaCode
301
CY2022 dei Local Phone Number
LocalPhoneNumber
315-0027
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.15 par value
CY2022 dei Trading Symbol
TradingSymbol
AGX
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Public Float
EntityPublicFloat
382871469
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14815609
CY2022 dei Auditor Firm
AuditorFirmId
248
CY2022 dei Auditor Location
AuditorLocation
Arlington, Virginia
CY2022 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509370000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
409638000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
330139000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
245817000
CY2022 us-gaap Gross Profit
GrossProfit
99732000
CY2021 us-gaap Gross Profit
GrossProfit
62067000
CY2020 us-gaap Gross Profit
GrossProfit
-6820000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47321000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39041000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44125000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7901000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
44510000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
23026000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-55840000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2552000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1859000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8075000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47062000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24885000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47765000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11356000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2022 us-gaap Profit Loss
ProfitLoss
35706000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2538000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-40000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1977000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
38244000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23851000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-42689000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1370000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
35000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-770000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36874000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23886000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-43459000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.43
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.73
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.40
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.73
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15715000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15668000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15621000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15913000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15825000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15621000
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.00
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350472000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366671000
CY2022Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
90026000
CY2021Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
90055000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26978000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28713000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4904000
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
26635000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34904000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34146000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
507284000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
546220000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10460000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20361000
CY2022Q1 us-gaap Goodwill
Goodwill
28033000
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3322000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4097000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
457000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
249000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4029000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3760000
CY2022Q1 us-gaap Assets
Assets
553585000
CY2021Q1 us-gaap Assets
Assets
602630000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
41822000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53295000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53315000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50750000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
127890000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
172042000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
223027000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
276087000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4963000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4135000
CY2022Q1 us-gaap Liabilities
Liabilities
227990000
CY2021Q1 us-gaap Liabilities
Liabilities
280222000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15788673
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15706202
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15257688
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15702969
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2368000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2356000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158190000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
153315000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
188690000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
166110000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
530985
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3233
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
20405000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
33000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2451000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1081000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
326392000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
320667000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
-797000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
1741000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
325595000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322408000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
553585000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602630000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
394372000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-770000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2131000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1630000
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15621000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
341030000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
35000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2938000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1641000
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
47047000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322408000
CY2022 us-gaap Profit Loss
ProfitLoss
35706000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-1370000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3459000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1428000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20372000
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15664000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
325595000
CY2022 us-gaap Profit Loss
ProfitLoss
35706000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7901000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3459000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2938000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2131000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
3391000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1820000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1004000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2381000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
16000
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
20000
CY2022 us-gaap Depreciation
Depreciation
3367000
CY2021 us-gaap Depreciation
Depreciation
3715000
CY2020 us-gaap Depreciation
Depreciation
3513000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
870000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
904000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1136000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-208000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7645000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6640000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-424000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-625000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-869000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
480000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8463000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1038000
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-21741000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-6744000
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-24978000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
241000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11467000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2357000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5742000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31442000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3284000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-44154000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
99357000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
64336000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28415000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176013000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53565000
CY2022 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
90000000
CY2021 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
170000000
CY2020 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
166000000
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
90000000
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
100000000
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
195000000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5016000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1333000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1422000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1697000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7058000
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
600000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7038000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
66970000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36058000
CY2022 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
15664000
CY2021 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47047000
CY2020 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
15621000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20372000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1428000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1641000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1630000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34608000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45406000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13991000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2968000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1731000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-471000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16199000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
199308000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3045000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366671000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167363000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164318000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350472000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366671000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167363000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><i style="font-style:italic;">Use of Estimates</i> – The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues, expenses, and certain financial statement disclosures.  Management believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to it at the time that these estimates, judgments and assumptions are made. Estimates are used for, but are not limited to, the Company’s accounting for revenues, the valuation of assets with long and indefinite lives including goodwill, the valuation of restricted stock units and options to purchase shares of the Company’s common stock, the evaluation of contingent obligations and uncertain income tax return positions, the valuation of deferred taxes, and the determination of the allowance for doubtful accounts. Actual results could differ from these estimates.</p>
CY2022Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
40400000
CY2021Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
36800000
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
7900000
CY2022Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
7500000
CY2021Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
16600000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
397000000.0
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.84
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509370000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2400000
CY2022Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2400000
CY2022 us-gaap Goodwill Impairment Loss Net Of Tax
GoodwillImpairmentLossNetOfTax
0
CY2019Q1 us-gaap Goodwill
Goodwill
32838000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2020Q1 us-gaap Goodwill
Goodwill
27943000
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
90000
CY2022Q1 us-gaap Goodwill
Goodwill
28033000
CY2022Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
16500000
CY2022 agx Period Of Amortization Of Goodwill For Income Tax Purpose
PeriodOfAmortizationOfGoodwillForIncomeTaxPurpose
P15Y
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11050000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7728000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3322000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4097000
CY2020 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2021 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2022 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
392000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
392000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
376000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
300000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1150000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3322000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
712000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31445000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38723000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20985000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18362000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10460000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20361000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7900000
CY2022 us-gaap Depreciation
Depreciation
3400000
CY2021 us-gaap Depreciation
Depreciation
3700000
CY2020 us-gaap Depreciation
Depreciation
3500000
CY2022 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
2100000
CY2021 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1900000
CY2020 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
3400000
CY2022Q1 agx Amount Outstanding Letter Of Credit Issued By Bank In Support Of Project Development Activities And Deposited In Bank As Collateral
AmountOutstandingLetterOfCreditIssuedByBankInSupportOfProjectDevelopmentActivitiesAndDepositedInBankAsCollateral
3400000
CY2022 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
3400000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1800000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
3300000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2000000.0
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P46M
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.025
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
3500000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
3000000.0
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1457000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
538000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
379000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
277000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
230000
CY2022Q1 agx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1029000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3910000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
254000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3656000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1367000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2289000
CY2022Q1 agx Remaining Bonded Performance Obligations
RemainingBondedPerformanceObligations
235100000
CY2022 agx Bonds Outstanding Covering Other Risks
BondsOutstandingCoveringOtherRisks
1000000.0
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2300000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1900000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1140000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.01
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M14D
CY2019Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
11.22
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
238000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.76
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.67
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
46000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
48.47
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1271000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.83
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M4D
CY2020Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
11.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
242000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
37.26
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
68000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
57.44
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1405000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.17
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2021Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.39
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
67000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
45.47
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
42000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
34.01
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
54.28
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1405000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.35
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M1D
CY2022Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.31
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
938000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
46.09
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M12D
CY2021Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
11.58
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1110000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
45.19
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M21D
CY2022Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
10.98
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
375000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
10.05
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
238000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.60
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
134000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
10.25
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
31000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
10.28
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
448000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.74
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
242000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.53
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
207000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
9.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
16000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.52
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
467000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.01
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
67000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.54
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
231000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
8.46
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
8000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
7.05
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
295000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.80
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2200000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1800000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3500000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2900000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2100000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6000000.0
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2022 agx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Period For Monthly Closing Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeriodForMonthlyClosingPrices
P5Y
CY2022 agx Percentage Reduction In Aggregate Fair Value Of Stock Option
PercentageReductionInAggregateFairValueOfStockOption
0.885
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.50
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
10921000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-6654000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-77000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
643000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
83000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-336000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11564000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-6571000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-413000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-341000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7720000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6825000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
133000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-75000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
185000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-208000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7645000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6640000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11356000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9883000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5226000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10030000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
614000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-81000
CY2022 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
1296000
CY2021 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
420000
CY2020 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
420000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15621000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.43
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.73
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.40
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.73
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 agx Effective Income Tax Rate Reconciliation Bad Debt Loss
EffectiveIncomeTaxRateReconciliationBadDebtLoss
425000
CY2021 agx Effective Income Tax Rate Reconciliation Bad Debt Loss
EffectiveIncomeTaxRateReconciliationBadDebtLoss
-160000
CY2020 agx Effective Income Tax Rate Reconciliation Bad Debt Loss
EffectiveIncomeTaxRateReconciliationBadDebtLoss
-6205000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-352000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-173000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
722000
CY2021 agx Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Benefits Amount
EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardBenefitsAmount
-4392000
CY2020 agx Effective Income Tax Rate Reconciliation Net Operating Loss Benefits Elimination Amount
EffectiveIncomeTaxRateReconciliationNetOperatingLossBenefitsEliminationAmount
7239000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
763000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-510000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
146000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
119000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11356000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2022 agx Income Tax Benefit Federal And State
IncomeTaxBenefitFederalAndState
6200000
CY2022 agx Allowance For Loan And Lease Loss Recovery Of Bad Debts Tax
AllowanceForLoanAndLeaseLossRecoveryOfBadDebtsTax
400000
CY2022 agx Increase In Loss Carryback Period For Certain Losses
IncreaseInLossCarrybackPeriodForCertainLosses
P5Y
CY2022Q1 agx Domestic Net Operating Loss Carryback
DomesticNetOperatingLossCarryback
39500000
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8300000
CY2022 agx Net Operating Loss Carryback Rate Difference Benefit Amount
NetOperatingLossCarrybackRateDifferenceBenefitAmount
4400000
CY2022 agx Period For Identify And Quantify Research And Development Tax Credits
PeriodForIdentifyAndQuantifyResearchAndDevelopmentTaxCredits
P3Y
CY2022Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16600000
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
400000
CY2021Q1 agx Unrecognized Income Tax Benefits Related To Research And Development Credits
UnrecognizedIncomeTaxBenefitsRelatedToResearchAndDevelopmentCredits
5000000.0
CY2022Q1 agx Unrecognized Income Tax Benefits Related To Research And Development Credits
UnrecognizedIncomeTaxBenefitsRelatedToResearchAndDevelopmentCredits
5000000.0
CY2022Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
29500000
CY2021Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
26900000
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14360000
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14192000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2325000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2549000
CY2022Q1 agx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
772000
CY2021Q1 agx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
775000
CY2022Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
269000
CY2022Q1 us-gaap Share Price
SharePrice
38.60
CY2022Q1 agx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
768000
CY2021Q1 agx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
770000
CY2022Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
43000
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
176000
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6712000
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7228000
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3513000
CY2022Q1 agx Deferred Tax Liabilities Property Plant And Equipment And Other
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndOther
1334000
CY2021Q1 agx Deferred Tax Liabilities Property Plant And Equipment And Other
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndOther
1801000
CY2022Q1 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
1034000
CY2021Q1 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
968000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12404000
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11797000
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
457000
CY2020Q3 agx Common Stock Special Dividends Per Share Cash Paid
CommonStockSpecialDividendsPerShareCashPaid
1.00
CY2020Q4 agx Common Stock Special Dividends Per Share Cash Paid
CommonStockSpecialDividendsPerShareCashPaid
1.00
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
527752
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20400000
CY2021Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
102000
CY2022Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
19000
CY2021Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
234000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1828000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1422000
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19573000
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19274000
CY2022Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3533000
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
249000
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5900000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5000000.0
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1300000
CY2022 us-gaap Investment Tax Credit
InvestmentTaxCredit
4500000
CY2021 us-gaap Investment Tax Credit
InvestmentTaxCredit
1100000
CY2022Q1 agx Cash Investment Commitments
CashInvestmentCommitments
0
CY2022 agx Investments Term
InvestmentsTerm
P6Y
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000000.0
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5500000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3100000
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
200000
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1000000.0
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
8400000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
38244000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23851000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-42689000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15715000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15668000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15621000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
198000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
157000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15913000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15825000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
570167
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
638001
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1303000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11356000
CY2022 us-gaap Profit Loss
ProfitLoss
35706000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
870000
CY2022 us-gaap Depreciation
Depreciation
3367000
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1422000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509370000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
409638000
CY2022 us-gaap Gross Profit
GrossProfit
99732000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47321000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7901000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
44510000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2552000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47062000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
507284000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
223027000
CY2022Q1 us-gaap Goodwill
Goodwill
28033000
CY2022Q1 us-gaap Assets
Assets
553585000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
330139000
CY2021 us-gaap Gross Profit
GrossProfit
62067000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39041000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
23026000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1859000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24885000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
904000
CY2021 us-gaap Depreciation
Depreciation
3715000
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1697000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
546220000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
276087000
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2021Q1 us-gaap Assets
Assets
602630000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
245817000
CY2020 us-gaap Gross Profit
GrossProfit
-6820000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44125000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-55840000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8075000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47765000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1136000
CY2020 us-gaap Depreciation
Depreciation
3513000
CY2020 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7058000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
421755000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
144034000
CY2020Q1 us-gaap Goodwill
Goodwill
27943000
CY2020Q1 us-gaap Assets
Assets
487540000

Files In Submission

Name View Source Status
0001558370-22-005383-index-headers.html Edgar Link pending
0001558370-22-005383-index.html Edgar Link pending
0001558370-22-005383.txt Edgar Link pending
0001558370-22-005383-xbrl.zip Edgar Link pending
agx-20220131.xsd Edgar Link pending
agx-20220131x10k.htm Edgar Link pending
agx-20220131x10k001.jpg Edgar Link pending
agx-20220131x10k002.jpg Edgar Link pending
agx-20220131x10k_htm.xml Edgar Link completed
agx-20220131xex10d8.htm Edgar Link pending
agx-20220131xex23d1.htm Edgar Link pending
agx-20220131xex31d1.htm Edgar Link pending
agx-20220131xex31d2.htm Edgar Link pending
agx-20220131xex32d1.htm Edgar Link pending
agx-20220131xex32d2.htm Edgar Link pending
agx-20220131_cal.xml Edgar Link unprocessable
agx-20220131_def.xml Edgar Link unprocessable
agx-20220131_lab.xml Edgar Link unprocessable
agx-20220131_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending